CLAVISTAR D.S.

FDA approved for acute bronchitis , Clavulanic Acid prevents Amoxycillin from 13-Lactamase degradation & effectively Extended microbial Spectrum ,Most active 3-Lactam agent pneumococci, 3-Lactamase producing Haemophilus influenzae & Moraxella catarrhalis Antimicr , Achieves superior cure rates as compared with Cefuroxime axetil in acute exacerbation of acute bronchitis, Achieves superior cure rates as compared with Cefaclor in acute urinary tract Infections.